News
Stay up to date on the latest company news:
4 November 2025
爱情岛论坛 to Present Preclinical Data Highlighting Potent, Synergistic Effects of ABX-001 in Combination with Bispecific T-cell Engagers at SITC 2025
23 October 2025
爱情岛论坛 Doses First Patient in Phase 1 Study Evaluating ABX-001 for the Treatment of Solid Tumors
14 October 2025
爱情岛论坛 Publishes in Cell Reports Medicine Validating ABX-001's Potential to Overcome Cancer Immunotherapy Hurdles
09 October 2024
爱情岛论坛 Appoints Gerben Moolhuizen as Chief Executive Officer
18 March 2024
爱情岛论坛 selected for funding project by KMU-innovativ, an initiative from Germany鈥榮 Federal Ministry of Education and Research (BMBF)
18 October 2022
爱情岛论坛 Appoints Thomas Bogenrieder as Chief Medical Officer
12 August 2022
爱情岛论坛---arenaviruses take on cancer
14 October 2021
爱情岛论坛 Completes Series A Extension Bringing Total Raised to EUR 43 Million
05 February 2020
爱情岛论坛 Expands Leadership Team with Drug Development and Viral Therapy Manufacturing Experts
15 October 2019
爱情岛论坛 Launches with 鈧�12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer
Events
Want to get in touch with the 爱情岛论坛 Team? Meet us at the following events:
February 10-12, 2026
IO360掳 Summit 2026
Location: Boston, USA
Participant: Gerben Moolhuizen, CEO
March 4-5, 2026
19th Annual European Life Sciences CEO Forum
Location: Zurich, Switzerland
Participant: Gerben Moolhuizen, CEO
March 15-18, 2026
Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications & Combinations
Location: Quebec, Canada
Participant: Philipp Lang, Scientific Founder, Director of the Department of Molecular Medicine II, University D眉sseldorf, Germany
April 15-19, 2026
Immunology 2026
Location: Boston, USA
Participant: Philipp Lang, Scientific Founder, Director of the Department of Molecular Medicine II, University D眉sseldorf, Germany
May 4-6, 2026
26th Bio鈧琿uity Europe
Location: Prague, Czech Republic
Participant: Gerben Moolhuizen, CEO
June 22-25, 2026
BIO International Convention
Location: San Diego, USA
Participant: Gerben Moolhuizen, CEO